MedTrace Logo

Anthocyanin Extract and Phospholipid Curcumin in Colorectal Adenoma

NCT01948661 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-11-21

Study results available
· View outcomes & findings →

Summary

It has been shown that curcumin and cyanidin-3-glucoside (C3G) have anticancer effects. In this clinical trial we compare the affect of their combination vs placebo in a four weeks intervention before endoscopic polypectomy.

Conditions

  • Colorectal Adenoma
  • Risk Reduction

Interventions

DIETARY_SUPPLEMENT

Mirtoselect® + Meriva®

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Fondazione Umberto Veronesi

    collaborator OTHER

  • Indena S.p.A

    collaborator INDUSTRY

  • Ente Ospedaliero Ospedali Galliera

    lead OTHER

Principal Investigators

  • Andrea DeCensi, MD · Medical Oncology Ente Ospedaliero Ospedali Galliera

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2019-01-31
Completion
2022-06-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01948661 on ClinicalTrials.gov